Every year, more than 130,000 Americans undergo aortic valve replacement. For the first time in 2020, more of these procedures were done in the cath lab than in the operating room. Conceived as an alternative for patients considered too high risk to undergo surgical aortic valve replacement (SAVR), TAVR has been approved by the U.S. […]
To continue reading this article or issue you must be a paid subscriber. Sign in
Subscribe to Heart Advisor
Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!